Atlas Trials

A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494

Clinical trial NCT01741493 · COMPLETED

Trial details

NCT number
NCT01741493
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2012-11-01
Primary completion
2013-12-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.